2030年までの北米神経刺激装置市場予測 - 地域分析 - 製品別(脊髄刺激装置、脳深部刺激装置、仙骨神経刺激装置、迷走神経刺激装置など)、用途別(疼痛管理、てんかん、尿失禁、便失禁、パーキンソン病) s 疾患など)、およびエンドユーザー(病院、専門クリニックなど)

BMIRE00030034 | Pages: 85 | Medical Device | Apr 2024 | Type: Regional | Status: Published
北米の神経刺激装置市場は、2022 年に 24 億 2,264 万米ドルと評価され、2030 年までに 50 億 80 万米ドルに達すると予想されています。 2022 年から 2030 年までに 9.5% の CAGR を記録すると推定されています。 神経疾患の有病率の増加が北米の神経刺激デバイス市場を促進 高齢者人口は神経疾患にかかりやすいです。高齢者が罹患する一般的な神経障害には、神経障害、パーキンソン病、アルツハイマー病、ジストニアなどがあります。国立衛生研究所 (NIH) によると、世界人口の 8.5% (つまり約 6 億 1,700 万人) が 65 歳以上です。米国やカナダなどの国では、高齢者人口の増加に伴い、運動障害や精神障害の有病率が高くなります。パーキンソン病財団によると、パーキンソン病の症状は平均 60 歳で一般的です。カナダ心理学会は、カナダの人口の約 2% が強迫性障害 (OCD) に罹患していると述べています。世界保健機関 (WHO) は、てんかんは発作を引き起こす神経疾患であり、次のような影響を与えると述べています。世界中で5,000万人。米国神経学会によると、脳卒中は米国の死因の第 3 位であり、アルツハイマー病が第 6 位となっています。同じ情報源からの統計によると、100万人近くのアメリカ人がパーキンソン病に罹患しており、毎年少なくとも6万人の新規症例が報告されている。うつ病や慢性疼痛などの生活習慣病と組み合わされた神経疾患の発生率の増加により、技術的に先進的な製品の採用が増加しています。 WHO によると、神経障害は?の原因となります。世界の疾病負担の6.3%。また、同じ情報源によると、この障害は世界中で主な死亡原因の 1 つとなっています。先進国では死亡の13.2%、低・中所得国では16.8%が死亡の原因となっています。死亡率と疾病負荷が高いため、長期的な解決策を統合することが臨床的に緊急に必要とされています。さらに、神経障害による多大な負担に関する認識の高まりにより、治療法としての神経刺激装置の需要が増加しています。したがって、神経疾患にかかりやすい高齢者人口の増加、疾患の有病率の増加、および神経疾患の多大な負担に関する意識の高まりが、神経刺激デバイス市場の成長を推進します。北米神経刺激デバイス市場の概要 北米神経刺激デバイス市場は、米国、カナダ、メキシコに分割されています。北米は、神経疾患の蔓延、研究開発への多額の支出、米国食品医薬品局(FDA)による製品承認、技術の進歩により、世界の神経刺激装置市場で大きなシェアを握ると予想されています。神経疾患にかかりやすい高齢者人口の増加は、予測期間中にこの地域の市場成長に有利な機会を提供すると予想されます。さらに、脳疾患に対する懸念の高まりに対処するための政府からの支援の拡大により、この地域の市場の成長が促進されると予想されます。米国では神経血管疾患の発生率が大幅に増加しており、全米の主な死因の一つとなっている。パーキンソン病(PD)などの神経疾患の発生率の上昇、神経疾患に対する意識の高まり、経頭蓋刺激装置の開発への投資の増加などが、米国の神経刺激装置市場全体を牽引する主な要因となっています。脳深部刺激(DBS)装置は、パーキンソン病に関連する震えを効果的に制御することが観察されています。ドーパミン値の低下やその他の遺伝的要因は、パーキンソン病の主な原因の 1 つです。北米神経刺激デバイス市場の収益と2030年までの予測(百万米ドル) 北米神経刺激デバイス市場セグメンテーション 北米神経刺激デバイス市場は、製品、アプリケーション、エンドユーザー、および国に基づいて分割されています。製品に基づいて、北米の神経刺激装置市場は脊髄刺激装置、脳深部刺激装置、仙骨神経刺激装置、迷走神経刺激装置などに分類されます。脊髄刺激装置セグメントは、2022 年に最大の市場シェアを獲得しました。アプリケーションの観点から見ると、北米の神経刺激装置市場は、疼痛管理、てんかん、尿失禁および便失禁、パーキンソン病などに分類されます。疼痛管理セグメントは、2022 年に最大の市場シェアを保持しました。北米の神経刺激デバイス市場は、エンドユーザーごとに病院、専門クリニックなどに分割されています。病院セグメントは、2022 年に最大の市場シェアを保持しました。北米の神経刺激デバイス市場は、国に基づいて米国、カナダ、メキシコに分割されています。 2022 年の北米神経刺激装置市場シェアは米国が独占しました。Medtronic Plc、Boston Scientific Corp、Abbott Laboratories、Nevro Corp、LivaNova Plc、Synapse Biomedical Inc、Nalu Medical Inc、ElectroCore Inc、MicroTransponder Inc、Mainstay Medical などがその一部です。北米の神経刺激デバイス市場で事業を展開する大手企業。
Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Neurostimulation Devices Market - Key Industry Dynamics

4.1 Market Drivers

4.1.1 Increasing Prevalence of Neurological Disorders

4.1.2 Rising Cases of Spinal Cord Injury

4.2 Market Restraints

4.2.1 Lack of Expert Professionals

4.3 Market Opportunities

4.3.1 Growing Advances and Approvals for Neurostimulation Devices

4.4 Future Trends

4.4.1 Rising Demand for Noninvasive Treatment

4.5 Impact Analysis

5. Neurostimulation Devices Market - North America Market Analysis

5.1 North America Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

6. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

6.1 Overview

6.2 North America Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)

6.3 Spinal Cord Stimulator

6.3.1 Overview

6.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Deep Brain Stimulator

6.4.1 Overview

6.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.5 Sacral Nerve Stimulator

6.5.1 Overview

6.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.6 Vagus Nerve Stimulator

6.6.1 Overview

6.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.7 Others

6.7.1 Overview

6.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

7.1 Overview

7.2 North America Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)

7.3 Pain Management

7.3.1 Overview

7.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Epilepsy

7.4.1 Overview

7.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Urinary and Fecal Incontinence

7.5.1 Overview

7.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Parkinson's Disease

7.6.1 Overview

7.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

8.1 Overview

8.2 North America Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)

8.3 Hospitals

8.3.1 Overview

8.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Specialty Clinics

8.4.1 Overview

8.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 - Country Analysis

9.1 North America: Neurostimulation Devices Market

9.1.1 Overview

9.1.2 North America: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)

9.1.2.1 US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.2 US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.2.1 US: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.2.2 US: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.2.3 US: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.3 Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.4 Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.4.1 Canada: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.4.2 Canada: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.4.3 Canada: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.5 Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.6 Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.6.1 Mexico: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.6.2 Mexico: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.6.3 Mexico: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

10. Neurostimulation Devices Market-Industry Landscape

10.1 Overview

10.2 Organic Developments

10.2.1 Overview

10.3 Inorganic Developments

10.3.1 Overview

11. Company Profiles

11.1 Medtronic Plc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Boston Scientific Corp

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Abbott Laboratories

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Nevro Corp

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 LivaNova Plc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Synapse Biomedical Inc.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Nalu Medical, Inc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 ElectroCore Inc

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 MicroTransponder Inc.

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 Mainstay Medical

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

List of Tables

Table 1. Neurostimulation Devices Market Segmentation

Table 2. US Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 3. US Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 4. US Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 5. Canada Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 6. Canada Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 7. Canada Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 8. Mexico Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 9. Mexico Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 10. Mexico Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 11. Organic Developments Done by Companies

Table 12. Inorganic Developments Done by Companies

Table 13. Glossary of Terms, Neurostimulation Devices Market

List of Figures

Figure 1. Neurostimulation Devices Market Segmentation, By Country

Figure 2. Neurostimulation Devices Market: Key Industry Dynamics

Figure 3. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints

Figure 4. North America Neurostimulation Devices Market Revenue (US$ Mn), 2020 - 2030

Figure 5. North America Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)

Figure 6. Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. North America Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)

Figure 12. Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. North America Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)

Figure 18. Hospitals & Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. North America: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)

Figure 22. North America: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)

Figure 23. US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

1. Medtronic Plc

2. Boston Scientific Corp

3. Abbott Laboratories

4. Nevro Corp

5. LivaNova Plc

6. Synapse Biomedical Inc

7. Nalu Medical, Inc

8. ElectroCore Inc

9. MicroTransponder Inc

10. Mainstay Medical

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America neurostimulation devices market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America neurostimulation devices market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America neurostimulation devices market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
  • Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


    Purchase Options
    Single User License
    $3550
    $2840
    Site License
    $4550
    $3640
    Enterprise License
    $5550
    $4440